Being a Caregiver: CAR T-Cell Therapy
This is a recording of the webinar, Being a Caregiver: CAR T-Cell Therapy, that aired on February 1, 2023.

This is a recording of the webinar, Being a Caregiver: CAR T-Cell Therapy, that aired on February 1, 2023.
This is a recording of the webinar, COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know, that aired November 16, 2022.
Acute myeloid leukemia is a diagnosis that affects mainly older adults. Treatment options depend on the type of AML a patient has, age, prior treatment and general health. Learn the details on how recommendations for treatment are determined.
Graft-versus-host disease (GVHD) is a frequent complication after a stem cell transplant using donor cells. GVHD can affect many parts of the body including the genitals.
Prevention and Treatment of Graft-versus-Host Disease (GVHD) - Video in Spanish
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.
More than 60,000 people have myelodysplastic syndrome (MDS) in the U.S. Learn about the best treatment options.
Learn challenges and coping strategies for caregivers of patients with graft-versus-host disease.
With cases of COVID-19 on the rise this winter, it's important to have the latest facts about your risk for getting a severe case of COVID-19.